NBRV - Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q3 2019 Results - Earnings Call Transcript
Nabriva Therapeutics plc (NBRV)
Q3 2019 Earnings Conference Call
November 12, 2019 04:30 PM ET
Company Participants
Gary Sender - Chief Financial Officer
Ted Schroeder - Chief Executive Officer
Francesco Maria Lavino - Chief Commercial Officer
Jennifer Schranz - Chief Medical Officer
Steve Gelone - President & Chief Operating Officer
Conference Call Participants
Alan Carr - Needham
Ishmael Asante - Morgan Stanley
Jason Gerberry - Bank of America
Robert Driscoll - Wedbush
Thomas Yip - H.C. Wainwright
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the Nabriva Third Quarter 2019 Financial Results Conference